Document is current
Any future updates will be listed below
-
Authors
Pera, Victor https://orcid.org/0000-0002-0786-4712
Kors, Jan A. https://orcid.org/0000-0002-4929-026X
van Mulligen, Erik M. https://orcid.org/0000-0003-1377-9386
de Wilde, Marcel
Rijnbeek, Peter R. https://orcid.org/0000-0003-0621-1979
Verhamme, Katia M. C. https://orcid.org/0000-0001-8162-4904
-
Funding
Funding for this research was provided by:
EHDEN (806968)
- License Information
-
More Information
Article History
Accepted: 14 August 2024
First Online: 19 September 2024
Declarations
:
: This work has received support from the European Health Data & Evidence Network (EHDEN) project. EHDEN has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 806968.
: The research group from the Department of Medical Informatics received unconditional research grants from Chiesi, UCB, Amgen, Johnson and Johnson, and the European Medicines Agency, none of which relates to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: An agreement has been made with the EMA not to transfer or dispose of the ICSR data set Level 2A for which access is provided under the condition of the Confidentiality Undertaking to any third party. It is agreed not to permit any third party to access, study, analyse, refer to or otherwise use the data or permit any party to reproduce any ICSR data. A publicly available version of this database is available here: . Further inquiries can be directed to the corresponding author.
: Not applicable.
: VP: conceptualisation, formal analysis, visualisation, writing (original draft), writing (review and editing), methodology, visualisation. JK: software, writing (review and editing). EV: software, writing (review and editing). MdW: software, writing (review and editing). PR: supervision, writing (review and editing). KV: conceptualisation, supervision, writing (review and editing). All authors read and approved the final version.
